受强制性开放获取政策约束的文章 - Aurelio Castrellon了解详情
可在其他位置公开访问的文章：2 篇
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial
CH Barcenas, SA Hurvitz, JA Di Palma, R Bose, AJ Chien, N Iannotti, ...
Annals of Oncology 31 (9), 1223-1230, 2020
强制性开放获取政策： US National Institutes of Health
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO …
S Hurvitz, R Singh, B Adams, JA Taguchi, D Chan, RA Dichmann, ...
Therapeutic advances in medical oncology 10, 1758835918807339, 2018
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定